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Mice liver microsomes oxidatively open the benzene ring to form trans,trans-muconaldehyde, a hemato-
toxic unsaturated aldehyde. In the present studies, 4.5 imole trans,trans-muconaldehyde was reacted with
"4C-2'deoxyguanosine 5'-phosphate inphosphate buffer. Products were separatedby highperformance liquid
chromatography (HPLC). Absorbance was monitoredusing adiode arraydetector, andaliquots ofthe HPLC
eluant were collected forUV spectrophotometric analysis andscintillationcounting. Underthese conditions,
deoxyguanosine 5'-phosphate eluted at 12.5 min and muconaldehyde at 22.0 min. The HPLC and radioac-
tivityprofiles ofthe muconaldehyde/deoxyguanosine reaction mixture indicated the presence ofmultiple ad-
ducts. Three adducts were detected eluting at36, 39, and 42 min, whichrepresented approximately 2.5, 2.5,
and 1% ofthe radioactivity, respectively. These adducts had similarUV spectra with absorption maximabe-
tween 334 and347 nm. Anotherproduct ofthe reactionmixture, eluting at 19.0 min andaccountingfor 10%
oftheradioactivity, wasalsoobserved. Thiscompoundhadabsorptionmaximaat348and372 nm. Theseresults
suggest that trans,trans-muconaldehyde can react with deoxyguanosine monophosphate in vitro underphys-
iological conditions to form stable adducts. Studies arebeingconducted to determine the structure ofthese
adducts andwhetherthese adducts are formedbythe reaction ofDNAwithmuconaldehyde ormetabolically
activated benzene.
Introduction
trans,trans-Muconaldehyde (TTM), an a,3-unsaturated
diene dialdehyde, has been suggested by Goldstein et al.
(1) to be a toxic intermediate in the metabolism ofben-
zene to trans,trans-muconic acid. Since the early studies
ofParke andWilliams it hasbeen known that benzene is
metabolized to this ring-opened dicarboxcylic acid (2).
Only recently, however, has ITM been identified as a
product of benzene metabolism in mouse liver micro-
somes (3). Enzymatic oxidation of muconaldehyde to
trans,trans-muconic acid by aldehyde dehydrogenase has
been shown to occur in both rat and mouse liver cytosol
(4). It has also been demonstrated that TTM is a potent
hematotoxin. Administration of3 mg/kgdaily for 16 days
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to CD-1 miceresultedin statistically significantdecreases
in erthrocyte count, hematocrit, and bone marrow cel-
lularity (5).
The present work describes the formation of adducts
by the reaction of TTM with deoxyguanosine
5'-phosphate. This study is the first step in determining
whether muconaldehyde-derived DNA adducts are im-
portant in the carcinogenicity of benzene.
Materials
8-14C-2'-Deoxyguanosine 5'-phosphate was obtained
from Schwarz/Mann and diluted with unlabeled deoxy-
guanosine 5'-phosphate (Sigma Chemical Co.) to aspecific
activityof0.82mCi/mmole. TTMwas synthesized accord-
ingtothemethodofKossmehl and Bohn(6)aspreviously
described (3).
Methods
Reacticn conditions. Onemilligram(4.5 *mole)of FTM
was added directly to 6 mg (9 ,umole) 8-14C-2'-deoxy-LATRIANO ETAL.
guanosine 5'-phosphate in 2 mL of 10 mM phosphate
buffer, pH 7.4, and the mixture was incubated at370 for
16 hr.
HPLCAnalysis. Products from the reaction mixture
were separated by high performance liquid chromatog-
raphy (HPLC) using a Phenomenex C-18 ,uBondapak
column and a gradient of 10 mM phosphate or 200 mM
ammonium acetate, pH 5.0, from0 to60% methanol over
a period of 60 min. Absorbance was monitored on-line
from 220 to 370 nm with an LKB diode array detector.
During HPLC analysis, 1 mL aliquots were collected to
whichwere added 10mL ofHydrofluor scintillation cock-
tail (National Diagnostics), and their associated radioac-
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tivitywas determined byusingan LKB Rackbetaliquid
scintillation counter. In addition, the UV spectraofradi-
oactive compounds eluting from the HPLC were ana-
lyzed using a Perkin-Elmer Lambda 3B spectrophotom-
eter.
Results and Discussion
Asillustrated in Figure 1, the chromatogram andradio-
activityprofile obtained afterHPLC analysis ofthereac-
tion ofTTM with deoxyguanosine 5'-phosphate contain
severalmajoradductpeaks that are not observed in the
deoxyguanosine 5'-phosphate control (Fig. 2). An exami-
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FIGURE 1. Chromatogram and radioactivity profile ofTTM with '4C-deoxyguanosine 5'-phosphate. Injection volume was 20ML; mobile phase was
a linear gradient of 10 mM phosphate, pH 5.0, and methanol. For other conditions see text.
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FIGURE 2. Chromatogram and radioactivity profile of '4C-deoxyguanosine 5'-phosphate. Injection volume was 10 JAL; mobile phase was a linear
gradient of 10 mM sodium phosphate, pH 5.0, and methanol. For other conditions see text.
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nation ofthe UV spectra ofthese adducts reveals the fol-
lowing: adducts 1, 2, and 3, eluting at 26, 39, and 42 min,
have absorption maxima at 334, 342, and 347 nm, respec-
tively (Fig. 3A-C). Adduct 1 has an additional maximum
at 272 nm, while adducts 2 and 3 have a shoulder at this
wavelength andanother shoulder at254nm. Inthe chro-
matogram of the muconaldehyde/deoxyguanosine mix-
ture at260 nm(Fig. 1), adducts 1 and2 appeartobe split
peaks. Expansion ofthe chromatograminthis regionand
on-line spectral analysis reveals that the spectra ofthe
material under each halfofthe split peaks are identical.
This finding suggests that these adducts may be a mix-
ture of diastereomers.
Inadditionto thethese adducts, there are severalother
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FIGURE 3. UV spectra of peaks 1-4 collected from the HPLC in 1- to
2-mL aliquots (injection volume 250M1L). Samples were in200mM am-
monium acetate: methanol. (A) Adduct 1, retention time, 36min; (B)
adduct 2, retention time, 39 min; (C) adduct 3, retention time, 42min;
(D) adduct 4, retention time, 19 min.
radioactive peaks inthis chromatogramthat are notpres-
ent in the control. The most prominent ofthese peaks is
the irregularly shaped peak eluting at 19 min (Fig. 1, no.
4). As shown in Figure 3D, this peak has an absorption
maximum at248 nm and a shoulder at272 nm. In subse-
quent analysis ofthereaction mixture, thispeak assumed
a more symmetrical shape.
The percent yields ofthe major adducts, based on the
radioactivity associated with 14C-deoxyguanosine, are ap-
proximately 2.5% for each the possible diastereomers of
adducts 1 and 2, 1% for adduct 3, and 14% for adduct 4.
Two other peaks with retention times of26 and 29 min
are associated with a small amount ofradioactivity, but
notenough material waspresent fora UV spectral anal-
ysis.
These studies demonstrate that TTM reacts under
physiological conditions to form adducts ofvariable sta-
bility. Diastereomeric cyclic 1,N2-deoxyguanosine ad-
ducts have been reported by other investigators (7,8) to
bethemajorproducts formed during the reactionofother
a,fi-unsaturated aldehydes with deoxyguanosine. The cy-
clic 1,N2-propanodeoxyguanosine adduct formed during
the reaction ofacrolein and crotonaldehyde with deoxy-
guanosine (7) has chromatographic and spectral charac-
teristics similar to that of the major muconaldehyde-
deoxyguanosine adduct(no. 4). Thefindingthat the other
adducts (nos. 1-3) have significant absorbance at longer
wavelengths may reflect the extended conjugation sys-
tem ofmuconaldehyde, which absorbs maximally at 272
nm. Studies are underway to determine the structure of
the adducts formedduringthereactionofmuconaldehyde
with deoxyguanosine, as well as to determine whether
similar adducts areformedby the reaction ofDNAwith
muconaldehyde or metabolically activated benzene.
This work was supported by NCI grant CA21111.
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